Get started
Award

MR/P011462/1

Funded outputs count: 81
Funder award ID: MR/P011462/1
OpenAlex ID: G4613715315
Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans
2024 · Felix A Westcott, Shilpa R Nagarajan, et al. · European Journal of Endocrinology · 3
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis
2024 · Dimitrios A. Koutoukidis, Sandi Yen, et al. · Gut Microbes · 31
PDF
Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction
2024 · Jeremy W. Tomlinson · Diabetes Obesity and Metabolism · 38
PDF
Alterations in plasma protein N-glycosylation after caloric restriction and bariatric surgery
2024 · Tamara Štambuk, Domagoj Kifer, et al. · Surgery for Obesity and Related Diseases · 6
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study
2024 · Hamish Miller, David Harman, et al. · BMJ Open · 2
PDF
A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study
2023 · Santo Colosimo, María A. Martínez-Sánchez, et al. · Nutrition Metabolism and Cardiovascular Diseases · 1
A low‐energy total diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis
2023 · Dimitrios A. Koutoukidis, Ferenc E. Mozes, et al. · Obesity · 18
PDF
Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy
2023 · Riccardo Pofi, Ilaria Bonaventura, et al. · Endocrine Connections · 10
PDF
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD
2023 · Thomas Marjot, Jeremy W Tomlinson, et al. · Gut · 83
PDF
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad ?
2023 · Riccardo Pofi, Giorgio Caratti, et al. · Endocrine Reviews · 215
Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database
2023 · Weiqi Liao, Carol A.C. Coupland, et al. · EClinicalMedicine · 22
PDF
Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study
2023 · Margarita Papatheodoridi, Giada Pallini, et al. · Clinical Gastroenterology and Hepatology · 26
PDF
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial
2023 · Nantia Othonos, Riccardo Pofi, et al. · Nature Communications · 43
PDF
Adopting a Citizen Science Approach in Translational Experimental Medicine Research in Non-Alcoholic Fatty Liver Disease: A Study Protocol
2023 · Syed Ghulam Sarwar Shah, Yolanda Barrado-Martín, et al. · Citizen Science Theory and Practice · 2
PDF
Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent
2022 · Santo Colosimo, Garry D. Tan, et al. · Nutrition Metabolism and Cardiovascular Diseases · 24
PDF
Glucocorticoid induced adrenal insufficiency
2022 · Aoife Garrahy, Jeremy W Tomlinson, et al. · BMJ · 15
Bile acids as drivers and biomarkers of hepatocellular carcinoma
2022 · Santo Colosimo, Jeremy W Tomlinson · World Journal of Hepatology · 37
Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
2022 · Laura Heath, Paul Aveyard, et al. · Hepatology Communications · 11
Clinical practice gaps and challenges in non‐alcoholic steatohepatitis care: An international physician needs assessment
2022 · Patrice Lazure, Jeremy W. Tomlinson, et al. · Liver International · 16
PDF
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
2022 · Connar S J Westgate, Keira Markey, et al. · European Journal of Endocrinology · 31
PDF
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
2022 · Stuart McPherson, Matthew J Armstrong, et al. · The Lancet. Gastroenterology & hepatology · 77
PDF
AKR1D1 knockout mice develop a sex-dependent metabolic phenotype
2022 · Laura L Gathercole, Nikolaos Nikolaou, et al. · Journal of Endocrinology · 16
PDF
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
2022 · Jonathan M. Hazlehurst, Teegan Reina Lim, et al. · Metabolism Open · 19
PDF
Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study
2022 · Nellie Y Loh, Edward Humphreys, et al. · European Journal of Endocrinology · 44
PDF
Is it time for chronopharmacology in NASH?
2022 · Thomas Marjot, David W. Ray, et al. · Journal of Hepatology · 31
PDF
Year
Topic